Insiders · Profile

Emany Sravan Kumar

Chief Financial Officer at Beam Therapeutics · SVP, COO and CFO at IRONWOOD PHARMACEUTICALS. Filing since 21 Nov 2022. CIK 0001897662

Company

Date

Role

Action

Amount

Of holding

31 Dec 2025

Chief Financial Officer

Sold on a plan

6,294

$170.57K

7.9%

18 Nov 2024

SVP, COO and CFO

Sold at will

11,001

$44.88K

3.4%

4 Mar 2024

SVP, Chief Financial Officer

Bought

10,684

$100.22K

3.7%

15 Sep 2023

SVP, Chief Financial Officer

Bought

36,072

$300.12K

23.6%

21 Nov 2022

SVP, Chief Financial Officer

Sold, plan not stated

6,578

$76.04K

7.7%

5 decisions on file.